Cost-Effectiveness of Afatinib and Erlotinib as Second-Line Treatments for Advanced Squamous Cell Carcinoma of The Lung in China

Jun Zhu(Anhui Medical University), B Su, M Ye(Renji Hospital), Yiqi Chu(Boehringer Ingelheim (China)), David Kuo(University of Pittsburgh), Y Zhang(Boehringer Ingelheim (China)), Jie Fu, Yiyang Zhao(Shanghai University of Traditional Chinese Medicine), Baojun Wu(Huazhong Agricultural University)
Value in Health
October 1, 2017
10.1016/j.jval.2017.08.250
Cited by 0

Related Papers

Association analyses identify six new psoriasis susceptibility loci in the Chinese population
|Nature Genetics|2010|317
Tracing of afferent and efferent pathways in the left inferior cardiac nerve of the cat using retrograde and transganglionic transport of horseradish peroxidase
|Brain Research|1984|156
Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway
|Phytomedicine|2021|122
Viruses Associated With Acute Respiratory Infections and Influenza-like Illness Among Outpatients From the Influenza Incidence Surveillance Project, 2010–2011
|The Journal of Infectious Diseases|2013|103
In Vivo Activation of cAMP Signaling Induces Growth Arrest and Differentiation in Acute Promyelocytic Leukemia
|The Journal of Experimental Medicine|2002|98